Why the study?
Adverse pregnancy outcomes like gestational diabetes and preeclampsia are unique cardiovascular risk factors that allow for early risk reduction counseling, but are often overlooked and not elicited by providers.
Adverse pregnancy outcomes are critical, early-emerging cardiovascular risk factors in women that warrant proactive pharmacological and nonpharmacological management.
Answers are grounded in this paper and cite their sources.
Supports incorporating pregnancy history into women's CVD risk evaluation; leaves open whether targeted interventions improve outcomes.
Cardiovascular disease (CVD) is the leading cause of death among women. Adverse pregnancy outcomes (APOs) are cardiovascular risk factors that are unique to women and include gestational diabetes (GDM) and preeclampsia. While these risk factors emerge during the reproductive years and allow for early risk reduction counseling, they are often overlooked and not elicited by providers. This mini-review focuses primarily on GDM and preeclampsia, their relationship with CVD, mechanisms by which these conditions lead to CVD, and management, pharmacological and nonpharmacological, for the clinician who is caring for a woman with a history of an APO.
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: